Neuland Pharma Research Private Limited, a amalgamated private limited company, was established on 23 April 2012 in Hyderabad, Telangana, India. Engaging in accounting and financial analysis within the professional, scientific and technical sector, it holds CIN: U73100TG2012PTC080474. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹9.50 Cr and a paid-up capital of ₹5.00 Cr.
Formerly known as Sucheth & Saharsh Pharmaceutical Research Private Limited. Employing 230 professional, Its leadership includes Ramamohan Davuluri Rao (Director), Saharsh Rao Davuluri (Director), Sucheth Rao Davuluri (Director). Past directors included Tirunelveli Padmanabhan Devarajan, Viswanath Venkata Subrahmanya Anjaneya Chibrolu. It holds no open charges and ₹261.90 Cr settled loans. Its latest AGM occurred on 28 December 2017, with the balance sheet filed on 31 March 2017. It is based at Sanali Info Park, 'A' Block, Ground Floor, 8-2-120/113, Road No. 2, Banjara Hills,, Hyderabad, Telangana, 500034.
U73100TG2012PTC080474
080474
23 April 2012
₹9.50 Cr
₹5.00 Cr
Roc Hyderabad
Unlisted
Amalgamated
Explore comprehensive insights into Neuland Pharma Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ramamohan Davuluri Rao | Director | 23 Apr 2012 | Current |
| Saharsh Rao Davuluri | Director | 23 Apr 2012 | Current |
| Sucheth Rao Davuluri | Director | 23 Apr 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 22 Jun 2017 | Past |
| Pramod Abcsdd | Alternate Director | 22 Jun 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Neuland Pharma Research Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 23.87% increase. The company also saw a substantial improvement in profitability, with a 169.49% increase in profit. The company's net worth Soared by an impressive increase of 62.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Neuland Pharma Research had a promoter holding of 99.99% and a public holding of 0.01%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹2,619,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2014 | Bank Of India | ₹20.00 Cr | Satisfied |
| 08 Aug 2013 | Export-Import Bank Of India | ₹10.00 Cr | Satisfied |
| 08 Aug 2013 | Export-Import Bank Of India | ₹30.00 Cr | Satisfied |
| 08 Aug 2013 | Sbi Global Factors Limited | ₹15.00 Cr | Satisfied |
| 08 Aug 2013 | Export-Import Bank Of India | ₹36.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Neuland Pharma Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Neuland Pharma Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Neuland Pharma Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Neuland Pharma Research Private Limited last Annual general meeting of members was held on 28 Dec 2017 as per latest MCA records. was documented.
The activity A charge registered on 27 Jun 2014 via Charge ID 10507554 with Bank Of India was fully satisfied on 07 Aug 2017. was completed.
The activity Neuland Pharma Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2017 with Roc Hyderabad. was completed.
The activity A charge registered on 08 Aug 2013 via Charge ID 10445664 with Export-Import Bank Of India was fully satisfied on 02 Mar 2017. was completed.
The activity A charge registered on 08 Aug 2013 via Charge ID 10446304 with Sbi Global Factors Limited was fully satisfied on 27 Oct 2016. was completed.
The activity A charge registered on 08 Aug 2013 via Charge ID 10445670 with Export-Import Bank Of India was fully satisfied on 19 Apr 2016. was completed.
Mumbai companies Minda Corp., Neuland Laboratories, and Simplex Infrastructure raised Rs837.79 crore through QIP offerings. Minda Corp. sold shares at Rs173.47 per share, showing investors' confidence in their business. Neuland Laboratories and Simplex Infrastructure also successfully raised funds through QIP. QIP is a way for listed companies to sell equity shares to qualified institutional buyers. In 2018, 17 companies have raised Rs11,049.8 crore through QIPs. In 2017, 43 companies raised Rs56,152 crore, the highest since 2009..
The CIN of Neuland Pharma Research Private Limited is U73100TG2012PTC080474.
Neuland Pharma Research Private Limited is headquartered at Sanali Info Park, 'A' Block, Ground Floor, 8-2-120/113, Road No. 2, Banjara Hills,, Hyderabad, Telangana, 500034.
Neuland Pharma Research Private Limited was incorporated on 23 April 2012.
The current directors of Neuland Pharma Research Private Limited are
The primary industry of Neuland Pharma Research Private Limited is Professional, Scientific And Technical.
Neuland Pharma Research Private Limited is unlisted.
The authorized capital of Neuland Pharma Research Private Limited is ₹9.50 Cr, and the paid-up capital is ₹5.00 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX